## Abstract Flowβcytometric DNA analyses of single cell nuclei were performed on nuclear suspensions prepared from biopsies of primary breast carcinomas in 638 patients. Propidiumβiodideβstained cell nuclei were analysed in an Ortho 50βH Cytofluorograph. The patients were staged by the TMN classifi
Correlation of dna flow cytometric results and other prognostic factors in primary breast cancer
β Scribed by G. E. Feichter; A. Mueller; M. Kaufmann; D. Haag; I. A. Born; U. Abel; K. Klinga; F. Kubli; K. Goerttler
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 598 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
The percentage of cells in S-phase and DNA-ploidy have been measured in 300 primary mammary carcinomas by means of DNA-flow cytometry (FCM). The data were compared with the age and menopausal status of the patients as well as with the size, regional lymph-node involvement, histologic type, grade and concentration of estrogen (ER) and progesterone (PR) receptors of the tumors. A DNA-diploid distribution of the Go,l-peak was found in 37.69b of the cases. The mean percentage of S-phase fractions was 4.83. DNAaneuploid tumors had significantly higher amounts of S-phase fractions (6.12%) than DNA-diploid tumors (2.66%). There was also a significant correlation between the DNA measurement data (DNA-ploidy and S-phase fractions) and histologic grade, as well as the content of ER and PR, but not between DNAploidy. S-phase fractions, tumor size (T) and evidence of axillary lymph-node metastases. DNA-FCM gives a biological characterization of the tumor in addition to the histopathologic examination. The method can be used as a routine procedure because of the reliability and reproducibility of the results as well as the short time needed for the measurements.
π SIMILAR VOLUMES
A large group of patients with node-positive breast cancer was divided into a training set (n = 851) and a validation set (n = 432) to demonstrate techniques for integrating steroid hormone receptor status, DNA flow cytometric findings, and other prognostic factors to predict patient survival. Multi
Breast cancer proliferative capacity as determined by the DNA thymidine labeling index, along with estrogen and progesterone receptor status, is highly predictive for risk of relapse and overall survival. Recently, DNA ploidy and proliferative capacity (Sphase fraction ISPFJ) as determined by flow c